'
In This Section:
More:
In This Section:

The ASTS Nominating Committee is pleased to put forward the following ballot for 2018 Officer and Councilor-at-Large positions. Below are the candidates, along with their personal photos, biographies, and summaries of their ASTS involvement. 

Eligible voting members will be sent an email from Vote Now with a unique link to their ballot. If you believe you are eligible to vote and did not receive a ballot, please contact nominations@asts.org.

Voting closes April 2, 2018.

Candidate for President-Elect:
Lloyd E. Ratner, MD, MPH
Candidates for Treasurer:
William C. Chapman, MD
Carlos O. Esquivel, MD, PhD
James F. Markmann, MD, PhD
Candidates for Councilor-at-Large:
Kenneth A. Andreoni, MD
Matthew Cooper, MD
Michael J. Englesbe, MD
Julie K. Heimbach, MD
Debra L. Sudan, MD
Kenneth Washburn, MD

President-Elect (Vote for 1)

Ratner
Lloyd E. Ratner, MD, MPH
Professor of Surgery
Director, Renal & Pancreatic Transplantation
Columbia University/New York-Presbyterian Hospital 

  • Treasurer (2015 – present)
    • Chairman, Finance Committee
    • Member, Executive Committee
    • ASTS-AST Joint Council
  • Member, ASTS-AST Joint Metrics Task Force (2017 – present)
  • Member, Obesity Task Force (2017 – present)
  • Councilor-at-Large (2012 – 2015)
    • Nominating Committee (2013 – 2015)
    • Councilor Liaison, Advanced Transplant Providers Committee
    • Councilor Liaison, Diversity Issues Committee
    • Councilor Liaison, Living Donation Committee
    • Councilor Liaison, Scientific Studies Committee
  • Member, Living Donation Committee (2010 – 2013)  
    • Previous Member ASTS/AST/NATCO Joint Societies Workgroup on Living Kidney Donor Policy Development
  • Member, Awards Committee (2007 – 2010)
  • Member, Development Committee (2006 – 2007)
  • Member, Informatics & Data Management Committee (2000 – 2003)

I am honored to be a nominee for the position of President Elect of the ASTS. I first joined the ASTS in 1993, and I am currently serving my third and final year as Treasuer of the Society. I have been privileged to be able to contribute to the ASTS over the years, and I am heartened by what a vibrant organization the Society has become. During my tenure as Treasurer, the ASTS reached our long stated goal of $20 million in assets, to assure the longterm financial viability.  This occurred with a concomitant expansion of the Society’s mission. The ASTS has a dynamic vision to advance the art and science of transplant surgery through leadership, advocacy, education, and training, and to serve needs of the membership. I believe that the future of the ASTS is very bright. That does not mean that it is without its challenges. As transplantation, and the health care environment evolve, the ASTS will need to have forward thinking, nimble, engaged, dedicated leadership, who are capable of communicating effectively with the membership to best meet their needs and that of their patients. Importantly, we need to create the environment that fosters innovation and progress, that have been the hallmarks of our discipline. With my past involvement in the ASTS I have an excellent understanding of the Society’s vision, needs and direction.

In addition to my service to the ASTS, I have extensive experience in many other facets of transplantation. I am a multi-organ transplant surgeon, although currently my practice is focused on kidney and pancreas transplantation. I direct the Renal & Pancreatic Transplantation Program at Columbia University. I have been a thought leader and an innovator. In 1993 I performed the world’s first dual renal transplant. In 1995 Louis Kavoussi, MD, and I performed the first laparoscopic donor nephrectomy and set the stage for its widespread adoption. I devised the plasmapheresis/IVIg protocol for alloantibody desensitization in 1998. In 2001, I orchestrated the second paired-kidney exchange in the U.S. In 2007, I first proposed utilization of compatible donor/recipient pairs in KPD. As an investigator, I have been federally funded and have authored over 180 peer-reviewed publications. As an educator, I have trained over 35 clinical and research fellows, many of whom have gone on to prominence. Previously, I sat on the UNOS Board and served on that organization’s Information Technology Advisory Committee, and the MPSC. Additionally, I sat on the boards of directors for three OPOs and served as the chairman of the Board of Directors of the New York Organ Donor Network, where I initiated a major strategic overhaul resulting in significant performance improvement.

I received my MD from Hahnemann University. My surgery training was obtained at Long Island Jewish Medical Center. I completed a Fellowship in Transplantation Surgery and Immunology at Washington University. In 2011, I completed a Master of Public Health with a focus on health care policy and management. 

I welcome the privilege to serve as the President Elect of our Society, for the betterment of its members, our patients, and the evolving discipline of transplantation.

Treasurer (Vote for 1)

Chapman_ballot photo 2018

William C. Chapman, MD, FACS
Eugene M. Bricker Chair of Surgery
Professor and Chief, Section of Transplantation
Chief, Division of General Surgery
Surgical Director, Transplant Center
Washington University School of Medicine

  • Councilor-At-Large (2015 – present)
    • Nominating Committee (2016 - 2018)
    • Councilor Liaison, MACRA Taskforce
    • Councilor Liaison, Grants Review Committee
    • Councilor Liaison, Living Donation Committee
    • Councilor Liaison, Membership Committee
  • Recipient, Francis Moore Excellence in Mentorship in the Field of Transplantation Surgery Award (2017)
  • Chair, Business Practice Committee (2012 – 2015)
  • Co-Chair, Business Practice Committee (2010 – 2012)
  • Member, Awards Committee (2007 – 2010)
  • Member, ATC Planning Committee (2005 – 2007)

I am honored and excited to be included in the slate for Treasurer within the ASTS. I have been involved with the Society over the 25-plus years of my career in abdominal transplantation and have been privileged to serve on the ATC Planning Committee, the ASTS Awards Committee, as previous co-chair and chair of the Business Practice Services (BPS) Committee, and as Councilor-at-Large, for which I will be ending my current term later this year. In all of these roles, I have come to appreciate the critical position of ASTS in the field of transplantation, including the training of surgeons and affiliated specialties, and in unique advocacy for patients with end stage organ failure, especially those requiring transplant surgery.

The ASTS Leadership is composed of many members with unique backgrounds that enhance the effectiveness of our association. In addition to my perspectives from previous Society involvement, there are several facets I would highlight. First, I am heavily involved in the field of abdominal transplantation, as both a center and division director of a large and established transplant program, with a strong history in the field of training and education. Second, I currently serve as a Director to the American Board of Surgery (ABS) and serve as chair of the Transplant Advisory Committee (TAC), which provides important input to ASTS and ABS regarding the training of surgeons focused in the field of transplant surgery. This will become especially important as the ASTS works to develop a certification process for trainees completing specialized fellowship training in the field of transplantation. In addition, a significant portion of my career focus has been in the field of HPB surgery. I am Past President of the Americas Hepato-Pacreato-Biliary Association (AHPBA) and am a strong believer that some of the best qualified surgeons for HPB surgery are those with advanced expertise in the field of transplant surgery. I have recently been asked to lead the effort to add HPB modules to the Academic Universe. This initial effort is well underway and we will have 12 new modules focused on HPB surgery by the start of the new academic year.

The ASTS has built an impressive infrastructure to support our trainees, members, and patients and these are all dependent on sound fiscal policy. Two years ago, I had the privilege to join the newly created Finance Committee, formed to provide guidance to the Treasurer and Council for investment decisions for our nearly $20 million in reserves. Our committee and the organization’s success has allowed the Council to increase funding for the annual research grant program, yet at the same time create a budget that will support efforts to enhance our training and certification process for many years to come, as well as continue our advocacy efforts. In short, the work of the ASTS Treasurer could not be more important today, and I feel well positioned to lead this effort. 

I am excited about the potential for continued participation in the mission of the ASTS and would be privileged to serve as Treasurer, if elected.  


Dr. Carlos Esquivel

Carlos O. Esquivel, MD, PhD
The Arnold and Barbara Silverman Professor of Surgery
Chief of the Division Abdominal Transplantation
Associate Director of the Institute for Immunity, Transplantation and Infection at Stanford School of Medicine
Director, Liver Transplant Program at Stanford Hospital and Clinics
Director, Liver Transplant Program at Lucile Packard Children’s Hospital at Stanford
Director of the Transplant Surgery Fellowship at Stanford University

  • Councilor-at-Large (2015 – present)
  • Recipient, Francis Moore Excellence in Mentorship in the Field of Transplantation Surgery Award (2015)
  • Chair, Pediatric Task Force Committee (2016 – Present)
  • Senior Advisor, Vanguard Committee (2014 – 2015)
  • Senior Advisor, ASTS Winter Symposium Planning Committee (2014 – 2015)
  • Member, Standards on Organ Procurement Committee (1997 – 2000)
  • Member, Membership Committee (1991 – 1994) 

The most important characteristic for being an effective treasurer is experience. During my journey as a transplant surgeon, I have directed multi-billion dollar budgets for both clinical and research programs from the time I finished my fellowship to the present. I created two of the most successful liver transplant programs in the country when few existed and little was known about how to undertake such an enterprise. First at California Pacific Medical Center, San Francisco and subsequently Stanford University, which I lead to this day. Currently, I am the Principal Investigator of a 7 million dollar multi-institutional U01 grant on mechanistic studies, requiring careful monitoring of complex budgets from 7 prominent institutions. Such experience in developing budgets and generating income to develop successful programs uniquely positions me to provide the highest support to our ASTS President and Council. 

Another essential quality of an effective treasurer is trustworthiness. It is important to choose the right path and remain committed to pursuing the Society’s goals and initiatives for the greatest outcomes, despite unforeseen challenges as I have consistently done throughout my career. I have remained devoted to all facets of adult and pediatric transplantation including research and education. For my mentorship I was recognized by the Society with the ASTS 2015 Francis Moore Excellence in Mentorship in the Field of Transplantation Surgery Award.

I have cultivated effective communication skills cutting across not only different career platforms but also diverse cultural perspectives. I am known to be approachable, unselfish and a consensus builder. I have always encouraged novel ways of thinking about how to achieve goals, which will continue to be of utmost importance as Treasurer.  

Transplant surgery is experiencing significant changes; therefore, it is critical for the Treasurer to work closely with ASTS leadership to best lead us along the path of becoming the world-leading transplant society. My vision for direction involves embracing change and creating an environment for fostering discovery, education, responsible leadership, and the generation of novel ways to strategically solve fiscal challenges-both old and new.

As Treasurer I would:

  1. Ensure the ASTS operates in a fiscally accountable manner to move the Society forward on our mission and objectives.
  2. Grow the endowment in a responsible manner to support innovative projects in research, education and professional development to create the future leaders of transplantation surgery.
  3. Advance the field of transplantation by facilitating partnerships between the Society and academic and other research institutions across the country to solve the organ shortage crisis, tailor or eliminate the need for immunosuppression, and improve the longevity of transplanted organs.

I am especially thankful for being nominated as Treasurer because it allows me the chance to provide dynamic leadership to expand programs and services benefitting the Society-at-large. I promise to reach our goals while cultivating the success of all current and future members. Opportunity for achievement can and should be enjoyed by everyone. Please join me in this journey! I would be honored if you give me your vote. Thank you!


Markmann

James F. Markmann, MD, PhD
Chief, Division of Transplant Surgery
Director of Clinical Operations
Co-Director, Center for Transplantation Sciences
Massachusetts General Hospital
Claude E. Welch Professor of Surgery
Harvard Medical School

  • Councilor-At-Large (2013 – 2016)
    • Nominating Committee (2015 – 2016)
    • Councilor Liaison, Cellular Transplantation Committee
    • Councilor Liaison, Regulatory and Reimbursement Committee
    • Councilor Liaison, Legislative Committee
  • ASTS Representative – Joint Society Working Group (2014 – 2016)
  • Chair, ATC Planning Committee (2010 – 2011)
  • Co-chair, ATC Planning Committee (2009 - 2010)
  • Co-chair, Ethics Committee (2008 – 2009)
  • Member, ATC Planning Committee (2006 – 2007)
  • Chair, Cell Transplant Committee (2005 – 2008)
  • Member, Awards Committee (2002 – 2004)
  • Recipient, ASTS Mid-Level Faculty Grant (2002)
  • Member, Cell Transplant Committee (2002 – 2006)

It is an honor to be considered a candidate for the position of ASTS Treasurer and it would be a privilege to serve the Society in this capacity. 

The ASTS has been a part of my academic life since attending the annual meeting in the early 1980s at the Drake Hotel. The Society has grown and matured dramatically in the past few decades to become a critical force in all aspects of the field of transplantation. I believe I possess the experience, energy, enthusiasm and vision to contribute substantively to the Society’s leadership and mission of advancing the practice and science of transplantation for the benefit of our patients, trainees, and society members.

Currently I lead the Division of Transplantation at Mass General. I am clinically active in kidney, liver, pancreas and islet transplantation as well as hemodialysis access. I serve as the Director of Clinical Operations and co-Director of the Center for Transplantation Sciences for the MGH Transplant Center and as Fellowship Director for our abdominal transplant program. I have contributed diversely to the transplant field through numerous societies, and organizations including: ASTS, AST, JDRF, TTS, IPITA (President Elect), ITN, NIH and UNOS and have served on editorial boards including AJT, Transplantation and Surgery. 

I view my qualifications for the Treasurer position to rest in three areas. First, is that I have a proven record of commitment to and accomplishment for the Society and would work diligently on behalf of the Society and its membership as part of ASTS leadership team. My clinical experience operating across organs and exposure working at both small and large programs will allow me to represent the broad interests of the membership.

Second, I have devoted a considerable portion of my career to advancing Transplantation science. Various factors have coalesced to erode the capacity of surgeons to train for and to contribute to scientific progress in our field including work hour restrictions, lower NIH pay-lines, and increasing prioritization by Surgery departments of RVU’s over academic productivity. Yet, there is little doubt that surgeons have a unique ability to contribute to advancing the care of our patients through scientific discovery and translation, and that the solutions to our biggest problems of an inadequate organ supply and the need for toxic immunosuppression will only be solved by scientific innovation. I would champion this view as a member of the ASTS leadership.

Finally, I have gained a broad perspective on the issues facing our field and our membership. I had the good fortune to become captivated by Transplantation when entering college and in the ensuing four decades had the opportunity to be trained by and work with some of Transplant’s great leaders and to have helped train many who I expect will be the leaders of tomorrow. Through these activities, I have acquired a deep understanding of the critical needs and wants of the Society’s membership. I have relished my work with Society to date and would welcome another opportunity to serve the ASTS and its membership.

Councilors-at-Large  (Vote for 3)

Andreoni
Kenneth A. Andreoni, MD
Associate Professor of Surgery
Division Chief, Abdominal Transplant Program
Surgical Director, Adult and Pediatric Kidney / Pancreas Transplant Program
The University of Florida College of Medicine

  • Chair, Business Practice Services Committee (2015 – present)
  • Chair, Leadership Development Program Planning Committee (2015 – present)
  • Chair, Advanced Leadership Development Program Planning Committee (2017)
  • Member, MACRA Task Force (2015 – present)
  • Member, Performance Metric Task Force (2014 – present)
  • Co-Chair, Business Practice Services Committee (2014 – 2015)
  • ASTS Academic Universe online curriculum author

It is truly an honor to be nominated as a candidate for Councilor-at-Large in the American Society of Transplant Surgeons. Like most of you, I see the ASTS as the beacon in our field of solid organ transplantation. I first joined the ASTS as a fellow in 1996 and became a full member in 1998.

My career is dedicated to transplantation across many areas: clinical, policy, and administrative. I currently lead a multi-organ center at the University of Florida, and actively perform kidney, pancreas, liver, and donor procurement surgeries. I have been a trainee or faculty at several different types of programs affiliated with various OPOs, including: surgical residency and research fellowship at Johns Hopkins under Drs. Mel Williams and Jim Burdick; clinical fellowship under Dr. Ron Ferguson at The Ohio State University, where I was also honored to rejoin later as faculty; my first faculty position at the University of Arizona; and finally where my children call home, the University of North Carolina, where I began my years of service with OPTN/UNOS. Working at these various centers and being very involved with each OPO gives me important insight into how every center is unique while sharing many common practices and concerns.

I was fortunate to have an inside view of how hard the ASTS works for its members early in my training career as Drs. Williams, Burdick, and Ferguson were very active in both our organization and in OPTN/UNOS. Much of my initial service to our transplant community has been through the OPTN/UNOS structure. During fourteen consecutive years of service, I moved from regional kidney committee representative to kidney committee chair, MPSC chair, board president, and then board advisor. During my time at UNOS, I started the ship turning to improve the collegiality between UNOS and all transplant organizations. I believe our ASTS relationship with the UNOS staff continues to be more open than in prior years. The ASTS is now my organizational passion, as I believe we must stay firmly united with all other transplant patient and professional organizations to move our field forward. The ASTS founded this revolutionary medical and scientific miracle, and should continue to be its best spokesperson. Serving as chair of the Business Practice Services Committee for the last three years has intensified my concern for the future of how we can continue to supply our life saving services to our patients. We must be leaders in the development and implementation of both reasonable regulatory quality oversight expectations, and financial reimbursement models that include access for all our patients and members.

The ASTS alone can unite our transplant surgical community and address the diverse needs of transplant professionals. I believe my experiences with policy development, government regulation, and my leadership in transplant business initiatives will allow me to serve the best interests of the entirety of the ASTS membership and our patients. Please support me in representing you as Councilor-at-Large in the ASTS.


Cooper

Matthew Cooper, MD
Director, Kidney and Pancreas Transplantation
Medstar Georgetown Transplant Institute
Professor of Surgery
Georgetown University School of Medicine

Medical Director, Quality and Safety
Medstar Georgetown University Hospital

  • Chair, ATC Planning Committee (2017 – present)
  • Co-Chair, ATC Planning Committee (2016-2017)
  • Member, ATC Planning Committee (2012 – 2016)
  • Member, Curriculum Committee (2008 – 2011)
  • Member, Scientific Studies Committee (2006 – 2009)

I am grateful for the nomination as candidate for Councilor-at-Large in the ASTS and would request your consideration. I have been an active clinical transplant surgeon since completing my fellowship at Johns Hopkins in 2002. I currently serve as the Director of a large volume Kidney and Pancreas Transplant Program and the Director of Quality and Safety at Medstar Georgetown University Hospital. My primary research interest is in the field of ischemia/reperfusion in kidney transplantation and interventions for DGF.

I have been actively involved in the ASTS since joining in 2000. Much of my service to our transplant community has been through the ASTS. I served on the Scientific Studies Committee from 2006-2009. Additionally, I served as an inaugural member of the Curriculum Committee from 2008-2011 which spearheaded the development and initial implementation of the Academic Universe where I oversaw all kidney and pancreas modules. Since 2012, I have served on the ATC planning committee where I currently have the privilege of representing the ASTS and our membership as its Chair. In this role I have observed great leadership, invited collaboration with our transplant surgical colleagues at all levels, and patterned my personal leadership style towards a goal of engagement and inclusiveness. Beyond ASTS, I currently serve as UNOS Region 2 Councilor and a member of its Board of Directors as well as current leadership activities with IPITA, NKF, NKR and the AFDT, sponsor of the annual Hume lecture at the ASTS Winter Symposium. I believe these combined experiences have prepared me for the next step as ASTS Councilor-at-Large.

Most recently I chaired a successful Consensus Conference to Decrease Organ Discards which included a diverse ASTS presence as well as representation from HRSA, UNOS, CMS, NIH, private payers, and patients. Both the immediate and ongoing enthusiasm for bringing this long anticipated event to fruition has been rapidly followed with several ongoing initiatives including projects with the ASTS Standards Committee evaluating kidney allograft biopsies, discussions with UNOS regarding facilitated allocation for high risk organs, and substantive dialogue with CMS to promote innovation and reduce risk aversion. The opportunities and like initiatives across all organs, no longer an ideal, now appear meaningful and real. As a result I was recently requested by UNOS leadership to co-chair the Systems Performance Summit , a planned national representative group of surgeons, physicians, OPOs, and community thought leaders whose purpose will be to identify methods to improve donation and transplant delivery systems and through that mechanism, increase organs transplanted and decease disparities and discards.

I have valued my last decade and a half of experience in service to the ASTS. I would like to introduce the diverse initiatives of our Society including education, training, and advocacy to even a broader audience. My primary location alone in the District will permit my presence for the issues and collaborations that demand an immediate audience with Congress and regulatory bodies. I truly believe I am well positioned to address the needs of the Society, its membership and to be its voice when called upon. I will not take my responsibility or this position for granted. As such, I would be honored if your confidence allows you to vote for me as an ASTS Councilor-at-Large.


Englesbe
Michael J. Englesbe, MD
Cyrenus G. Darling Sr. & Cyrenus G. Darling Jr. Professor of Surgery
University of Michigan
  • Member, ATC Planning Committee (2017 – present)
  • Chair, Winter Symposium Planning Committee (2014 – 2016)
  • Chair, Vanguard Committee (2013 – 2016)
  • Recipient, Vanguard Prize (2011)
  • Co-chair, Vanguard Committee (2010 – 2013)
  • Member, Vanguard Committee (2009 – 2010)
  • Member, CME Committee (2009 – 2011)

It is an honor to be considered as an ASTS Councilor-at-Large. I am humbled to be considered deserving to serve this great organization.

I practice liver and kidney transplantation at the University of Michigan. I have a particular interest in pediatric portal hypertension and pediatric liver transplantation. I run the 3rd and 4th year medical school curriculum at Michigan. I have several research activities focusing on best practice implementation, pain management, prehabilitation, and patient reported outcomes. These efforts are funded by the NIH, CMS, CDC, SAMSHA, Michigan HHS, and Blue Cross and Blue Shield of Michigan. I direct the Michigan Surgical Quality Collaborative, with a goal of making the State of Michigan the safest place for surgery in the United States.

My service to ASTS has filled my entire 11 years as a faculty member at Michigan. My work is highlighted by 6 years of service to the Vanguard Committee. I had the honor of chairing the Winter Meeting planning committee for 3 years. Our focus during this time was augmenting engagement from trainees. Proudly, we were able to significantly increase participation from students, residents, and fellows manifold.

As a councilor, I will focus my efforts to enhancing the talent pipeline into transplant surgery and increasing the approachability and inclusiveness of the Society. I will seek to increase the engagement of trainees and junior faculty. As an educator, I will bring a diverse perspective to the leadership of this remarkable team.


Heimbach
Julie K. Heimbach, MD
Professor of Surgery
Chair, Division of Transplant Surgery
Mayo Clinic
Rochester, MN
  • Member, Obesity Taskforce (2017 – present)
  • Chair, Communications Committee (2016 – present)
  • Co-chair, Communications Committee (2013 – 2016)
  • Member, Communications Committee (2010 – 2013)
  • Vanguard Committee (2007 – 2009)

I am honored to be nominated as a candidate for ASTS Councilor-at-Large.  My surgical career has been focused on transplantation since completion of my fellowship in 2002, and I am currently the division chief of a multi-organ transplant program in the USA. My primary areas of interest are living donor transplantation, liver transplant for malignancy such as HCC/CCA, and issues of obesity and transplantation.

I have also been dedicated to serving to the transplant community through my efforts in the ASTS, the AASLD, and UNOS/OPTN. I have been actively involved in the ASTS since the completion of my fellowship. Though there are many organizations engaged in the field of transplantation, the ASTS plays a crucial role as an organization due to our patient/ practice advocacy initiatives, research support and networking opportunities available for our members, and the strength of our education and training efforts which ensure the competence and quality of our field going forward. My initial involvement was as a member of the Vanguard committee and in that role I served to help plan the annual winter meeting. Following that role, I served on the communications committee as a member, then subsequently became the vice chair, and now the chair. During my tenure, I have been able to work on a major website redesign, as well as enhancements to the Chimera and more recently, we are focused on enhancing social media use within our organization. In addition to my ASTS committee service, I have demonstrated my commitment to the ASTS through service as an abstract review chair for ATC nearly every year for the last 10 years, as well as contributing content to the learning modules on the ASTS curriculum, and have volunteered as a reviewer for research grants submitted to the ASTS for funding consideration.

In addition to my work in the ASTS, I have served on several committees within the AASLD, and am currently completing a term of service on the Governing Board of the AASLD which has been a very valuable experience. Finally, I have had significant leadership experience through my engagement in UNOS/OPTN. I have served 2 tours on the Membership and Professional Standards Committee, as well as serving as the Region 7 representative to the UNOS/OPTN Board of Directors. I have also been elected as the region 7 representative to the Liver-Intestine Committee and subsequently vice-chair and now chair of the Liver-intestine committee. 

I do believe transplant is a unique field within medicine in that it requires tremendous engagement from the transplant community to continue to meet the needs of our patients both through our research and practice innovations, as well as our policy initiatives. I think these are the key areas of focus for the ASTS in the near term. My prior leadership roles within the ASTS, AASLD and UNOS/OPTN have prepared me well for service on the ASTS Council, and I would greatly value your vote for me as a Councilor-at-Large.


Sudan

Debra L. Sudan, MD
Professor of Surgery
Division Chief, Transplant Surgery
Duke University Medical Center
  • Member, TransQIP Task Force (2017 – present)
  • Member, ATC Planning Committee (2010 – 2012)
  • Member, Critical Care Task Force (2009 – 2012)
  • Member, Membership Committee (2008 – 2011)
  • Member, Ad Hoc Committee on Professional Reimbursement (2004 – 2005)
  • Member, Ad Hoc Committee on Workforce (2002 – 2012)
  • Member, Program, Publications & Postgraduate Course (2002 – 2005) 

I earned my medical degree and completed my General Surgery training at Wright State University in Dayton, OH in 1989 and 1994, respectively.  My Transplant Surgical Fellowship training was completed at the University of Nebraska in 1996. Currently, I serve as the Surgical Director of the Transplant Surgery Programs at Duke University since 2008.  My clinical and academic career has been devoted to kidney, pancreas, liver and intestine transplantation and the care of patients with end organ failure, especially intestinal failure. My research has been focused on clinical outcomes and biomarkers and my administrative efforts have been concentrated in quality improvement.

For me the American Society of Transplant Surgeons (ASTS) is the most important society I participate in, as it addresses crucial issues of interest to me as a transplant surgeon. It is also one of the most vibrant and active societies that I have participated in with measurable deliverables from each of the committees. Some of the activities and work within the society that I am most proud to have participated in include contributing to policy development in partnership with UNOS committees, developing and implementing the fellows curriculum, organizing, attending and/or leading leadership symposia for program leaders as well as fellows in training and national meetings (ATC), and the development and piloting of TransQIP in partnership with the American College of Surgeons National Surgical Quality Improvement Program, as a quality improvement tool for the transplant community.  I am currently serving on the ASTS Standards & Quality Committee. In addition to my service in the ASTS and my contributions clinically, in research and administratively at Duke, I have served in many additional organizations through committee membership and/or leadership roles to serve the needs of patients and providers in transplantation. These include the United Network for Organ Sharing (UNOS/OPTN), Carolina Donor Services Medical Advisory Board, American Society of Transplantation (AST), Intestinal Rehabilitation and Transplant Association (IRTA) and The Transplantation Society (TTS).  These experiences I believe have given me a broad background in many aspects of transplantation and organ donation and I believe will help provide important context for me to be effective as a Councilor in the ASTS.

It is an honor and privilege to be nominated as a candidate for the position of Councilor-at-Large in the American Society of Transplant Surgeons and if elected I promise to work diligently to advance the interests of all transplant surgeons and to work together with the Council to complete the important goals and mission of the Society.


Washburn_ballot photo 2017
Kenneth Washburn, MD
Executive Director, Comprehensive Transplant Center
Chief, Division of Transplant Surgery, Department of Surgery
Professor of Surgery
The Ohio State University Wexner Medical Center
  • Member, ASTS Finance Committee (2016 – present)
  • Chair, Curriculum Committee (2013 – 2016)
  • Co-Chair, Curriculum Committee (2010 – 2012)
  • Member, Curriculum Committee (2009 – 2010)
  • Member, ATC Planning Committee (2008 – 2010)
  • Member, Ethics Committee (2005 – 2008)
  • Member, Standards Committee (2004 – 2007)

I have been an ASTS member since 1995 and have enjoyed the benefits of this membership ever since. I have had the good fortune of serving the ASTS continuously since 2004 in a number of different capacities. It has become abundantly clear to me over this time that we must be a strong voice and promoter for the causes of our patients, our trainees and ourselves. There is no greater avenue for this advocacy than through our own society, the ASTS. A continued strong voice is necessary in these days of competing interests to keep our issues front and center to those that can help us move our agenda forward. Surgeons have been and need to continue to be the strong leaders in our field. 

My prior experience as the director of a liver transplant program serving a large geographic and ethnically diverse population in San Antonio has been formative in my development. Likewise, serving as the medical director for that OPO provided me great insight to other aspect of transplantation. I now serve as the Executive Director of a large abdominal and thoracic transplant program. This experience continues to broaden my exposure and knowledge of transplantation across the clinical, regulatory, educational, academic and financial aspects of our field. 

I have served the ASTS continuously since 2004 in multiple capacities including the standards, ethics, ATC planning, curriculum and currently finance committees. Outside of ASTS I have been actively involved with UNOS since 2003. I have served in many capacities including chair of the Liver and Intestine Committee, MPSC, Policy Oversight, Regional Councilor, Board of Directors, Executive Committee and Corporate Advisory Committee. These experiences have been extraordinary in how they have shaped my understanding of transplantation. I feel honored to have had the opportunity to have served in these many capacities.

The breadth and depth of my experiences in multiple areas of transplantation have and will continue to serve me and the constituents I support well. I believe I am well positioned to be a strong advocate for the ASTS and its members and would be honored to serve as one of its councilors.